Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Berndt

Showing results (131-140 of 155) with videos related to

Pageof 16
Sort By:
The Journal of Mental Health Policy and Economics|July 26, 2016
Regional Variation in Physician Adoption of Antipsychotics: Impact on US Medicare ExpendituresJulie M Donohue, Sharon-Lise T Normand, Marcela Horvitz-Lennon, et al.
Psychopharmacology Bulletin|January 1, 1996
Improvement in subjective work performance after treatment of chronic depression: some preliminary results. Chronic Depression Study GroupS N Finkelstein, E R Berndt, P E Greenberg, et al.
Psychiatric Services (Washington, D.C.)|January 3, 2013
How quickly do physicians adopt new drugs? The case of second-generation antipsychoticsHaiden A Huskamp, A James O'Malley, Marcela Horvitz-Lennon, et al.
Medical Care|April 23, 2013
The impact of emerging safety and effectiveness evidence on the use of physician-administered drugs: the case of bevacizumab for breast cancerRena M Conti, Stacie B Dusetzina, Ann C Herbert, et al.
The Journal of Clinical Psychiatry|November 26, 2002
The impact of treatment-resistant depression on health care utilization and costsWilliam H Crown, Stan Finkelstein, Ernst R Berndt, et al.
Health Affairs (Project Hope)|June 7, 2021
Biosimilars And Follow-On Products In The United States: Adoption, Prices, And UsersAriel Dora Stern, Jacqueline L Chen, Melissa Ouellet, et al.
Frontiers in Health Policy Research|December 23, 2004
Benefit plan design and prescription drug utilization among asthmatics: do patient copayments matter?William H Crown, Ernst R Berndt, Onur Baser, et al.
Journal of Health Economics|September 4, 1998
Workplace performance effects from chronic depression and its treatmentE R Berndt, S N Finkelstein, P E Greenberg, et al.
The Journal of Clinical Psychiatry|August 24, 1999
The economic burden of anxiety disorders in the 1990sP E Greenberg, T Sisitsky, R C Kessler, et al.
Journal of Occupational and Environmental Medicine|June 15, 2004
The clinical and occupational correlates of work productivity loss among employed patients with depressionDebra Lerner, David A Adler, Hong Chang, et al.
Pageof 16

Showing results (131-140 of 155) with videos related to

Sort By:
Pageof 16
The Journal of Mental Health Policy and Economics|July 26, 2016
Regional Variation in Physician Adoption of Antipsychotics: Impact on US Medicare ExpendituresJulie M Donohue, Sharon-Lise T Normand, Marcela Horvitz-Lennon, et al.
Psychopharmacology Bulletin|January 1, 1996
Improvement in subjective work performance after treatment of chronic depression: some preliminary results. Chronic Depression Study GroupS N Finkelstein, E R Berndt, P E Greenberg, et al.
Psychiatric Services (Washington, D.C.)|January 3, 2013
How quickly do physicians adopt new drugs? The case of second-generation antipsychoticsHaiden A Huskamp, A James O'Malley, Marcela Horvitz-Lennon, et al.
Medical Care|April 23, 2013
The impact of emerging safety and effectiveness evidence on the use of physician-administered drugs: the case of bevacizumab for breast cancerRena M Conti, Stacie B Dusetzina, Ann C Herbert, et al.
The Journal of Clinical Psychiatry|November 26, 2002
The impact of treatment-resistant depression on health care utilization and costsWilliam H Crown, Stan Finkelstein, Ernst R Berndt, et al.
Health Affairs (Project Hope)|June 7, 2021
Biosimilars And Follow-On Products In The United States: Adoption, Prices, And UsersAriel Dora Stern, Jacqueline L Chen, Melissa Ouellet, et al.
Frontiers in Health Policy Research|December 23, 2004
Benefit plan design and prescription drug utilization among asthmatics: do patient copayments matter?William H Crown, Ernst R Berndt, Onur Baser, et al.
Journal of Health Economics|September 4, 1998
Workplace performance effects from chronic depression and its treatmentE R Berndt, S N Finkelstein, P E Greenberg, et al.
The Journal of Clinical Psychiatry|August 24, 1999
The economic burden of anxiety disorders in the 1990sP E Greenberg, T Sisitsky, R C Kessler, et al.
Journal of Occupational and Environmental Medicine|June 15, 2004
The clinical and occupational correlates of work productivity loss among employed patients with depressionDebra Lerner, David A Adler, Hong Chang, et al.
Pageof 16